1. Home
  2. EVAX vs NMTC Comparison

EVAX vs NMTC Comparison

Compare EVAX & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EVAX

Evaxion Biotech

HOLD

Current Price

$3.13

Market Cap

30.4M

Sector

Health Care

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$3.23

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVAX
NMTC
Founded
2008
2009
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4M
29.2M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
EVAX
NMTC
Price
$3.13
$3.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$11.67
$11.90
AVG Volume (30 Days)
28.5K
23.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
$328.20
$31.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$2.28
$0.55
52 Week High
$12.15
$5.40

Technical Indicators

Market Signals
Indicator
EVAX
NMTC
Relative Strength Index (RSI) 39.30 39.79
Support Level $2.92 $0.69
Resistance Level $3.62 $4.87
Average True Range (ATR) 0.29 0.20
MACD -0.02 -0.01
Stochastic Oscillator 21.91 27.18

Price Performance

Historical Comparison
EVAX
NMTC

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: